title: Metrifonate.
authors.affiliation: Adis International Limited, Auckland, New Zealand. demail@adis.co.nz
authors.forename: H M
authors.initials: HM
authors.lastname: Lamb
authors.forename: D
authors.initials: D
authors.lastname: Faulds
mesh_terms: D000284:Administration, Oral; D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D004311:Double-Blind Method; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D008568:Memory / Q000187:drug effects; D016032:Randomized Controlled Trials as Topic; D014236:Trichlorfon / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D002800:Cholinesterase Inhibitors; D014236:Trichlorfon